|
|
|
|
| LEADER |
01000caa a22002652c 4500 |
| 001 |
NLM325461236 |
| 003 |
DE-627 |
| 005 |
20250301162907.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231225s2021 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.cej.2021.130189
|2 doi
|
| 028 |
5 |
2 |
|a pubmed25n1084.xml
|
| 035 |
|
|
|a (DE-627)NLM325461236
|
| 035 |
|
|
|a (NLM)33994842
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Asif, Muhammad
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Diagnosis of COVID-19, vitality of emerging technologies and preventive measures
|
| 264 |
|
1 |
|c 2021
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Revised 08.09.2024
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status PubMed-not-MEDLINE
|
| 520 |
|
|
|a © 2021 Elsevier B.V. All rights reserved.
|
| 520 |
|
|
|a Coronavirus diseases-2019 (COVID-19) is becoming increasing serious and major threat to public health concerns. As a matter of fact, timely testing enhances the life-saving judgments on treatment and isolation of COVID-19 infected individuals at possible earliest stage which ultimately suppresses spread of infectious diseases. Many government and private research institutes and manufacturing companies are striving to develop reliable tests for prompt quantification of SARS-CoV-2. In this review, we summarize existing diagnostic methods as manual laboratory-based nucleic acid assays for COVID-19 and their limitations. Moreover, vitality of rapid and point of care serological tests together with emerging biosensing technologies has been discussed in details. Point of care tests with characteristics of rapidity, accurateness, portability, low cost and requiring non-specific devices possess great suitability in COVID-19 diagnosis and detection. Besides, this review also sheds light on several preventive measures to track and manage disease spread in current and future outbreaks of diseases
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Biosensors
|
| 650 |
|
4 |
|a Developing methods
|
| 650 |
|
4 |
|a Existing techniques
|
| 650 |
|
4 |
|a Preventive measures
|
| 650 |
|
4 |
|a SARS-CoV-2
|
| 700 |
1 |
|
|a Xu, Yun
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Xiao, Fei
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Sun, Yimin
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Chemical engineering journal (Lausanne, Switzerland : 1996)
|d 1999
|g 423(2021) vom: 01. Nov., Seite 130189
|w (DE-627)NLM098273531
|x 1385-8947
|7 nnas
|
| 773 |
1 |
8 |
|g volume:423
|g year:2021
|g day:01
|g month:11
|g pages:130189
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.cej.2021.130189
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 423
|j 2021
|b 01
|c 11
|h 130189
|